drugset / Trial / NCT01605331
Safety and Efficacy of SR-hGH (Sustained-release Human Growth Hormone, Declage Inj.)
NaSingle-groupOpen-labelTreatment
Summary
As studies demonstrate, the administration of recombinant human GH (rhGH) in adults with GH deficiency has been known to improve metabolic impairment and quality of life. Patients, however, do have to tolerate daily injections of GH (rhGH).
Timeline
- Start
- 2009-12
- Primary completion
- 2010-09
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | recombinant human GH | Protein / enzyme biologic | 2 mg | Subcutaneous |